Stocksigma LogoStocksigma Logo

Emcure Pharmaceuticals Schedules Board Meeting for Q2 FY27 Financial Results

Emcure Pharmaceuticals Limited has scheduled a Board of Directors meeting on 3rd Nov'26 to consider and approve its standalone and consolidated unaudited

Emcure Pharmaceuticals Schedules Board Meeting for Q2 FY27 Financial Results

Emcure Pharmaceuticals Ltd 路 Intimation 路 03 Nov 2026, 5:30 am

Emcure Pharmaceuticals Schedules Board Meeting for Q2 FY27 Financial Results Emcure Pharmaceuticals Limited has scheduled a Board of Directors meeting on 3rd Nov'26 to consider and approve its standalone and consolidated unaudited financial results for the quarter and half-year ended 30th Sep'26. Additionally, the trading window for dealing in company securities by designated persons and their relatives remains closed from 1st Oct'26 until 5th Nov'26 (48 hours post-earnings declaration) in compliance with SEBI insider trading regulations.

Original exchange filing (PDF)

More announcements from Emcure Pharmaceuticals Ltd

All Emcure Pharmaceuticals Ltd announcements